About this trial
Patients with chronic pain are often prescribed long-term opioid therapy, despite the serious risks and growing concerns related to opioid use. The Toronto General Hospital has created the world's first multidisciplinary perioperative Transitional Pain Service Program (TPSP) aimed at reducing the incidence and severity of chronic post-surgical pain. The TPSP incorporates a variety of mechanisms and interventions to help patients manage pain and to wean off opioids. The approach consists of: pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile self- management tool to help patients manage chronic pain more effectively. With the TPSP team, the investigators hope to continually assist patients to achieve a balance between the benefits and potential harms of opioid use to promote long-term health and well-being.
Eligibility criteria
Qualifiers
≥ 18 years of age
Taking 10 -- 400 mg of preoperative oral morphine equivalents daily
Any type of surgical procedure, with the exception of those with palliative intent or organ transplantation
Able to read and understand English as posed on the questionnaire surveys prior to informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Interventional Group
- Control Intervention